Global Market Study on Oral Solid Dosage Contract Manufacturing: Tablets Dosage Form to Register Significant Revenue Growth Through 2028


Oral Solid Dosage Contract Manufacturing  Market
  • Published On : Dec-2018 |
  • Pages : 218 Pages |
  • Format :

A recent market study published by company – “Oral Solid Dosage Contract Manufacturing Market: Global Industry Analysis 2013–2017 & Opportunity Assessment 2018–2028” – consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the oral solid dosage contract manufacturing market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the oral solid dosage contract manufacturing market during the forecast period. It can help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the oral solid dosage contract manufacturing market in the coming years. The report provides detailed information about the current and future growth prospects of the oral solid dosage contract manufacturing market in the most comprehensive way for the better understanding of readers.

Chapter 01 – Executive Summary

The report commences with the executive summary of the oral solid dosage contract manufacturing market, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the oral solid dosage contract manufacturing  market, key players and market dynamic snapshot.

Chapter 02 – Market Introduction

Readers can find detailed taxonomy and the definition of the oral solid dosage contract manufacturing market in this chapter, which will help readers to understand the basic information about the segments of oral solid dosage contract manufacturing market and list of key market participants included in the report.

Chapter 03 – Market Opportunity Analysis

This chapter provides readers with information about the most important macroeconomic and microeconomic factors that are instrumental in shaping the oral solid dosage contract manufacturing market. It helps readers to understand the critical market opportunities for at all nodes of value chain in global market.

Chapter 04 – Global Economic Outlook

This chapter includes snapshot on gross domestic products of prominent countries across seven regions in the scope of the report.

Chapter 05: Market Background

This section includes the evolution of market in past few years and current industry trends. Readers can find detailed market dynamics of the oral solid dosage contract manufacturing market in this chapter, It helps readers to understand the critical market dynamics such as drivers, challenges, market trends, and opportunities for market players in the oral solid dosage contract manufacturing market.

Chapter 06 – North America Oral Solid Dosage Contract Manufacturing Market Analysis 2013–2017 and Forecast 2018–2028

This chapter includes detailed analysis of the growth of the North America oral solid dosage contract manufacturing market along with historical market analysis and forecast. Readers can also find regional market dynamics and trends. This section also includes the growth prospects of the oral solid dosage contract manufacturing market in countries such as the U.S., and Canada.

Chapter 07 – Latin America Oral Solid Dosage Contract Manufacturing Market Analysis 2013–2017 and Forecast 2018–2028

The market performance of oral solid dosage contract manufacturing in North America is discussed on a country level (Brazil, Mexico, Argentina & rest of Latin America) in this section. The section also provides insights on regional market drivers, challenges and trends in Latin America oral solid dosage contract manufacturing market.

Chapter 08 – Western Europe Oral Solid Dosage Contract Manufacturing Market Analysis 2013–2017 and Forecast 2018–2028

This section provides country wise analysis of oral solid dosage contract manufacturing market in Western Europe. Countries covered in this section are Germany, Italy, France, U.K., Spain, and rest of Western Europe. Market attractiveness analysis by country is provided to identify potential of growth for key players in the market. The section highlights regional market drivers, restraints and trends for oral solid dosage contract manufacturing market.

Chapter 09 – Eastern Europe Oral Solid Dosage Contract Manufacturing Market Analysis 2013–2017 and Forecast 2018–2028

This chapter of the report introduces oral solid dosage contract manufacturing market in Russia, Poland and rest of Eastern Europe by providing detailed information about the growth avenues for market players in the region and growth prospects of the market based on its leading segments.

Chapter 10 – APEJ Oral Solid Dosage Contract Manufacturing Market Analysis 2013–2017 and Forecast 2018–2028

China, India, ASEAN, and Australia & New Zealand are the leading countries in the APEJ region that are the prime subject of assessment to obtain growth prospects of the APEJ oral solid dosage contract manufacturing market in this chapter. Readers can find thorough information about the growth parameters of the APEJ oral solid dosage contract manufacturing market during the period 2018-2028.

Chapter 11 – Japan Oral Solid Dosage Contract Manufacturing Market Analysis 2013–2017 and Forecast 2018–2028

Readers can find important factors that can make a huge impact on the growth of the oral solid dosage contract manufacturing market in Japan This chapter provides the overview of drivers, restraints, and trends in the Japan oral solid dosage contract manufacturing market.

Chapter 12 – MEA Oral Solid Dosage Contract Manufacturing Market Analysis 2013–2017 and Forecast 2018–2028

This chapter provides information on how oral solid dosage contract manufacturing market will grow in the major countries in MEA region, such as GCC Countries, South Africa, and rest of MEA during the period 2018–2028.

Chapter 13 – Competition Landscape and Company Profiles

This section provides a dashboard review of competition in global oral solid dosage contract manufacturing market. It details the comparative assessment of key service offerings to market segments and competitive position of key players in the global market.

Readers can find a comprehensive profiles of key players in oral solid dosage contract manufacturing market, including company overview, revenue shares, strategic overview, and recent company developments, production capacity and production base etc. Market structure analysis is provided to understand degree of competition in global oral solid dosage contract manufacturing market. Market players featured in the report include Recipharm AB, AbbVie Contract Manufacturing, Patheon N.V., Catalent Inc., NextPharma, Capsugel (Lonza Group AG), Aurobindo Pharma Limited (AuroSource), Siegfried AG, Piramal Pharma Solutions, and CordenPharma, among others.

Chapter 14 – Global Oral Solid Dosage Contract Manufacturing Market Analysis 2013–2017 and Forecast 2018–2028, By Region

With the geographical perspective, global oral solid dosage contract manufacturing market is analysed on a total of seven regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and the Middle East and Africa (MEA). Historical trends in the oral solid dosage contract manufacturing market and their effects on global market performance is discussed in this chapter.

Chapter 15 – Global Oral Solid Dosage Contract Manufacturing Market Analysis 2013–2017 and Forecast 2018–2028, By Dosage

Based on dosage form, the oral solid dosage contract manufacturing market is segmented into tablets (further sub-segmented in to immediate release, modified release, chewable tablets, effervescent tablets etc.), capsules (further sub-segmented in to hard gelatin capsules and softgels), powders & granules, lozenges & pastilles, gummies, etc. In this chapter, readers can find information about key trends and developments in oral solid dosage contract manufacturing market and market attractive analysis based on dosage form.

Chapter 16 – Global Oral Solid Dosage Contract Manufacturing Market Analysis 2013–2017 and Forecast 2018–2028, By End User

Based on the end user, the oral solid dosage contract manufacturing market is segmented into big pharma or Biotech companies, small & medium-size pharma or biotech companies, emerging or virtual pharma companies and nutraceutical Companies. In this chapter, readers can find information on how demand from each of these end users is shaped.

Chapter 17 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 18 – Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the oral solid dosage contract manufacturing market.

Rationalization of Scale and Flexible Capacity Model to Drive the Growth of the Oral Solid Dosage Contract Manufacturing Market in North America

The U.S.-based pharmaceutical companies incur high cost for research and development of new chemical entities. These efforts to increase the research capabilities have led to mergers, which ensure the required production capacity for new chemical entities (NCEs). However, this rationalization approach is also extending outsourcing of primary (API) and secondary (formulation) manufacturing. Outsourcing of secondary manufacturing of branded products also results in approximately 40% to 60% cost saving to the innovator company. Other than cost saving, innovator companies are also looking on to scale-up operations. On the other hand, oral solid dosage contract manufacturing organizations (CMOs) are trying to integrate themselves into the value chain of pharmaceutical companies. CMOs are building dedicated facilities or capacities for pharma companies, who prefer not to build it themselves. This new model of sharing construction, operations, technologies & functions and building groundwork for long-term manufacturing partnerships is expected to drive the growth of oral solid dosage contract manufacturing market in North America.

oral-solid-dosage-contract-manufacturing-market.jpg

High Supplier Switching Cost Expected to be the Major Challenge in the Growth of the Oral Solid Dosage Contract Manufacturing Market

In oral solid dosage contract manufacturing, information such as product formula has to be transferred from client (innovator) companies to suppliers (CMOs). This involves the risk related to data confidentiality and exclusivity. Manufacturing of finished dosage form is typically based on short-term contracts with service providers and there are chances that the service provider may become a competitor once the contract ends. Moreover, the buyers have to pay high switching cost to the service providers due to need for compatibility with the manufacturing equipment required. This is expected to limit the growth of global oral solid dosage contract manufacturing market.

Oral Solid Dosage Contract Manufacturing Organizations Continue to Differentiate Their Offerings in the Highly Fragmented Marketplace

Due to highly fragmented nature of the oral solid dosage contract manufacturing market, CMOs need to seek out new ways to differentiate their services from competitors and provide value-added services. Oral solid dosage contract manufacturing organizations are facing enormous pressure to achieve financial results and profits due to many reasons such as under-used supply chain, challenges to meet regulatory standards, etc. Oral solid dosage contract manufacturing organizations are competing for the same customers in an environment of increasing margin pressure and competition from new entrants. Majority of CMOs are looking to offset the differentiation through transforming from CMOs to CDMOs.

Consolidation of Oral Solid Dosage Contract Manufacturing Market to Provide One-stop-shop

In the last decade, the oral solid dosage contract manufacturing market has seen number of mergers and acquisitions. For instance, in July 2017, Lonza completed the acquisition of Capsugel LLC, which made the company a leading integrated service provider to the pharmaceutical companies. Most of the companies have grown by acquiring manufacturing plants, which are no longer strategic to the pharmaceutical companies. Despite of this, the global oral solid dosage contract manufacturing market is extremely fragmented and has large number of small CMOs. Consolidation will help the pharma companies to access all their formulation or drug development related activities at one-stop-shop.

Competitive Landscape

This section of the report features profiles of the key players operating in the oral solid dosage contract manufacturing market based on their market shares, differential strategies, service offerings, production capacity & production bases, and company dashboard. Examples of some of the key players featured in global oral solid dosage contract manufacturing market report include Recipharm AB, AbbVie Contract Manufacturing, Patheon N.V., Catalent Inc., NextPharma, Capsugel (Lonza Group AG), Aurobindo Pharma Limited (AuroSource), Siegfried AG, Piramal Pharma Solutions, and CordenPharma, among others.

Definition

Oral solid dosage contract manufacturing includes services that provide third-party manufacturing of pharmaceutical oral solid dosage formulations including tablets, capsules, powders & granules, and lozenges, among others.

About the Report

The company conducted a research study on the global oral solid dosage contract manufacturing market for the forecast period 2018 to 2028. The report offers a comprehensive evaluation of the business opportunities prevailing in the oral solid dosage contract manufacturing market along with insights on the market dynamics, market trend and opportunities, regulatory scenario, and others. The report elaborates the macroeconomic factors influencing the dynamics of oral solid dosage contract manufacturing market and its futuristic potential.

Segmentation

For the better understanding of readers, the report on oral solid dosage contract manufacturing market provides salient information about oral solid dosage contract manufacturing market in the most comprehensive manner. The oral solid dosage contract manufacturing market is segmented based on geography, dosage forms, and end users/customers, to analyze the segment-wise growth of the market. Based on geography, the global oral solid dosage contract manufacturing market is segmented into seven regions – North America,  Western Europe, Eastern Europe, Latin America, Asia-Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA). By dosage form, the oral solid dosage contract manufacturing market is segmented into five dosage forms, viz., tablets (further sub-segmented in to immediate release, modified release, chewable tablets, effervescent tablets etc.), capsules (further sub-segmented in to hard gelatin capsules and softgels), powders & granules, lozenges & pastilles, gummies etc. Based on end users/customers, the global oral solid dosage contract manufacturing market is segmented into big pharma or Biotech companies, small & medium-size pharma or biotech companies, emerging or virtual pharma companies and nutraceutical companies.

Additional Questions Answered

Some of the additional questions addressed in this report on the oral solid dosage contract manufacturing market-

  • What is the revenue potential of the oral solid dosage contract manufacturing market across regions of North America and Europe?
  • Who are the key players and their service portfolio and strategy in oral solid dosage contract manufacturing market?
  • What are major challenges influencing the growth of oral solid dosage contract manufacturing market?
  • What are major trends in the oral solid dosage contract manufacturing market?
  • What are the production capacities of key players in oral solid dosage contract manufacturing market?

Research Methodology

The oral solid dosage contract manufacturing market has been estimated based on market share analysis. The market was first calculated based on manufacturer annual sales for oral solid dosage contract manufacturing activities in different region/countries. The oral solid dosage contract manufacturing volume was estimated based on the demand from end users/customers, i.e., pharmaceutical and biopharmaceutical companies. Overall consumption of each dosage form (tablets, capsules, powders) in terms of volume was tracked for each country. We then identified the percentage share of in-house vs. outsourced manufacturing for each dosage form for each country. Followed by this, we identified the percentage split for each drug release pattern for each dosage form. Regional data was then accumulated from countries mapped in above exercise as per the scope of the study. Overall market volume is aggregated from the data collected in above exercise in each geography

Company Profiles

  • Recipharm AB
  • AbbVie Contract Manufacturing
  • Patheon N.V.
  • Catalent Inc.
  • NextPharma
  • Capsugel (Lonza Group AG)
  • Aurobindo Pharma Limited (AuroSource)
  • Siegfried AG
  • Piramal Pharma Solutions
  • CordenPharma
  • Others.
Back To Top